HEADER HYDROLASE/ANTIBIOTIC 26-SEP-13 4MXH OBSLTE 12-OCT-16 4MXH 5EUA TITLE CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 IN COMPLEX TITLE 2 WITH MOXALACTAM CAVEAT 4MXH CHIRALITY ERROR AT C22 ATOM OF MOX A 301. COMPND MOL_ID: 1; COMPND 2 MOLECULE: BEL-1; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: BLA(BEL1), BLABEL-1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-BEL-1 KEYWDS ANTIBIOTIC RESISTANCE, MOXALACTAM, OMEGA-LOOP, HYDROLASE-ANTIBIOTIC KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.MANGANI,C.POZZI,J.D.DOCQUIER,M.BENVENUTI REVDAT 2 12-OCT-16 4MXH 1 OBSLTE REVDAT 1 15-OCT-14 4MXH 0 JRNL AUTH S.MANGANI,C.POZZI,J.D.DOCQUIER,M.BENVENUTI,F.DE LUCA, JRNL AUTH 2 G.M.ROSSOLINI,L.POIREL JRNL TITL CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM BETA-LACTAMASE JRNL TITL 2 BEL-1 IN NATIVE FORM AND IN COMPLEX WITH IMIPENEM AND JRNL TITL 3 MOXOLACTAM JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 40684 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2159 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2950 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE SET COUNT : 156 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3932 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : -0.00000 REMARK 3 B13 (A**2) : -0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.148 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.138 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.093 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.055 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4104 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5571 ; 1.374 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 524 ; 5.646 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 176 ;35.491 ;23.864 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 701 ;13.266 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;16.490 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 637 ; 0.195 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3071 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2066 ; 1.587 ; 2.540 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2582 ; 2.415 ; 3.793 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2038 ; 2.037 ; 2.856 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6407 ; 5.142 ;22.223 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MXH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-OCT-13. REMARK 100 THE RCSB ID CODE IS RCSB082488. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.920 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42901 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 33.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.42700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 4MX4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4600, 20% MPD, 0.1M SODIUM REMARK 280 CITRATE, PH 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.26500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.32000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.45500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.32000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.26500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.45500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 LEU A 3 REMARK 465 LEU A 4 REMARK 465 LEU A 5 REMARK 465 TYR A 6 REMARK 465 PRO A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 LEU A 10 REMARK 465 PHE A 11 REMARK 465 LEU A 12 REMARK 465 VAL A 13 REMARK 465 ILE A 14 REMARK 465 PRO A 15 REMARK 465 ALA A 16 REMARK 465 PHE A 17 REMARK 465 ALA A 18 REMARK 465 GLN A 19 REMARK 465 ALA A 20 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 LEU B 3 REMARK 465 LEU B 4 REMARK 465 LEU B 5 REMARK 465 TYR B 6 REMARK 465 PRO B 7 REMARK 465 LEU B 8 REMARK 465 LEU B 9 REMARK 465 LEU B 10 REMARK 465 PHE B 11 REMARK 465 LEU B 12 REMARK 465 VAL B 13 REMARK 465 ILE B 14 REMARK 465 PRO B 15 REMARK 465 ALA B 16 REMARK 465 PHE B 17 REMARK 465 ALA B 18 REMARK 465 GLN B 19 REMARK 465 ALA B 20 REMARK 465 GLU B 159 REMARK 465 PRO B 160 REMARK 465 THR B 161 REMARK 465 LEU B 162 REMARK 465 ASN B 163 REMARK 465 THR B 164 REMARK 465 ASN B 165 REMARK 465 THR B 166 REMARK 465 PRO B 167 REMARK 465 GLY B 168 REMARK 465 ASP B 169 REMARK 465 VAL B 282 REMARK 465 HIS B 283 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN B 34 CG CD OE1 NE2 REMARK 470 GLU B 96 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 61 -141.31 56.27 REMARK 500 THR A 213 -141.71 -111.37 REMARK 500 CYS B 61 -117.49 -106.52 REMARK 500 ALA B 98 58.66 -156.62 REMARK 500 THR B 213 -141.84 -111.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 497 DISTANCE = 6.33 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3P7 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MOX B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MX4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 REMARK 900 (ORTHORHOMBIC FORM) REMARK 900 RELATED ID: 4MXB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 REMARK 900 IN COMPLEX WITH IMIPENEM REMARK 900 RELATED ID: 4MXG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF EXTENDED-SPECTRUM BETA-LACTAMASE BEL-1 REMARK 900 (MONOCLINIC FORM) DBREF 4MXH A 1 283 UNP Q3SAW3 Q3SAW3_PSEAI 1 283 DBREF 4MXH B 1 283 UNP Q3SAW3 Q3SAW3_PSEAI 1 283 SEQRES 1 A 283 MET LYS LEU LEU LEU TYR PRO LEU LEU LEU PHE LEU VAL SEQRES 2 A 283 ILE PRO ALA PHE ALA GLN ALA ASP PHE GLU HIS ALA ILE SEQRES 3 A 283 SER ASP LEU GLU ALA HIS ASN GLN ALA LYS ILE GLY VAL SEQRES 4 A 283 ALA LEU VAL SER GLU ASN GLY ASN LEU ILE GLN GLY TYR SEQRES 5 A 283 ARG ALA ASN GLU ARG PHE ALA MET CYS SER THR PHE LYS SEQRES 6 A 283 LEU PRO LEU ALA ALA LEU VAL LEU SER ARG ILE ASP ALA SEQRES 7 A 283 GLY GLU GLU ASN PRO GLU ARG LYS LEU HIS TYR ASP SER SEQRES 8 A 283 ALA PHE LEU GLU GLU TYR ALA PRO ALA ALA LYS ARG TYR SEQRES 9 A 283 VAL ALA THR GLY TYR MET THR VAL THR GLU ALA ILE GLN SEQRES 10 A 283 SER ALA LEU GLN LEU SER ASP ASN ALA ALA ALA ASN LEU SEQRES 11 A 283 LEU LEU LYS GLU VAL GLY GLY PRO PRO LEU LEU THR LYS SEQRES 12 A 283 TYR PHE ARG SER LEU GLY ASP LYS VAL SER ARG LEU ASP SEQRES 13 A 283 ARG ILE GLU PRO THR LEU ASN THR ASN THR PRO GLY ASP SEQRES 14 A 283 GLU ARG ASP THR THR THR PRO MET SER MET ALA GLN THR SEQRES 15 A 283 VAL SER LYS LEU ILE PHE GLY ASP THR LEU THR TYR LYS SEQRES 16 A 283 SER LYS GLY GLN LEU ARG ARG LEU LEU ILE GLY ASN GLN SEQRES 17 A 283 THR GLY ASP LYS THR ILE ARG ALA GLY LEU PRO ASP SER SEQRES 18 A 283 TRP VAL THR GLY ASP LYS THR GLY SER CYS ALA ASN GLY SEQRES 19 A 283 GLY ARG ASN ASP VAL ALA PHE PHE ILE THR THR ALA GLY SEQRES 20 A 283 LYS LYS TYR VAL LEU SER VAL TYR THR ASN ALA PRO GLU SEQRES 21 A 283 LEU GLN GLY GLU GLU ARG ALA LEU LEU ILE ALA SER VAL SEQRES 22 A 283 ALA LYS LEU ALA ARG GLN TYR VAL VAL HIS SEQRES 1 B 283 MET LYS LEU LEU LEU TYR PRO LEU LEU LEU PHE LEU VAL SEQRES 2 B 283 ILE PRO ALA PHE ALA GLN ALA ASP PHE GLU HIS ALA ILE SEQRES 3 B 283 SER ASP LEU GLU ALA HIS ASN GLN ALA LYS ILE GLY VAL SEQRES 4 B 283 ALA LEU VAL SER GLU ASN GLY ASN LEU ILE GLN GLY TYR SEQRES 5 B 283 ARG ALA ASN GLU ARG PHE ALA MET CYS SER THR PHE LYS SEQRES 6 B 283 LEU PRO LEU ALA ALA LEU VAL LEU SER ARG ILE ASP ALA SEQRES 7 B 283 GLY GLU GLU ASN PRO GLU ARG LYS LEU HIS TYR ASP SER SEQRES 8 B 283 ALA PHE LEU GLU GLU TYR ALA PRO ALA ALA LYS ARG TYR SEQRES 9 B 283 VAL ALA THR GLY TYR MET THR VAL THR GLU ALA ILE GLN SEQRES 10 B 283 SER ALA LEU GLN LEU SER ASP ASN ALA ALA ALA ASN LEU SEQRES 11 B 283 LEU LEU LYS GLU VAL GLY GLY PRO PRO LEU LEU THR LYS SEQRES 12 B 283 TYR PHE ARG SER LEU GLY ASP LYS VAL SER ARG LEU ASP SEQRES 13 B 283 ARG ILE GLU PRO THR LEU ASN THR ASN THR PRO GLY ASP SEQRES 14 B 283 GLU ARG ASP THR THR THR PRO MET SER MET ALA GLN THR SEQRES 15 B 283 VAL SER LYS LEU ILE PHE GLY ASP THR LEU THR TYR LYS SEQRES 16 B 283 SER LYS GLY GLN LEU ARG ARG LEU LEU ILE GLY ASN GLN SEQRES 17 B 283 THR GLY ASP LYS THR ILE ARG ALA GLY LEU PRO ASP SER SEQRES 18 B 283 TRP VAL THR GLY ASP LYS THR GLY SER CYS ALA ASN GLY SEQRES 19 B 283 GLY ARG ASN ASP VAL ALA PHE PHE ILE THR THR ALA GLY SEQRES 20 B 283 LYS LYS TYR VAL LEU SER VAL TYR THR ASN ALA PRO GLU SEQRES 21 B 283 LEU GLN GLY GLU GLU ARG ALA LEU LEU ILE ALA SER VAL SEQRES 22 B 283 ALA LYS LEU ALA ARG GLN TYR VAL VAL HIS HET 3P7 A 301 29 HET MOX B 301 29 HET CL B 302 1 HETNAM 3P7 (2R)-2-[(1R)-1-{[(2R)-2-CARBOXY-2-(4-HYDROXYPHENYL) HETNAM 2 3P7 ACETYL]AMINO}-1-METHOXY-2-OXOETHYL]-5-METHYLIDENE-5,6- HETNAM 3 3P7 DIHYDRO-2H-1,3-OXAZINE-4-CARBOXYLIC ACID HETNAM MOX (2R)-2-[(1R)-1-{[(2S)-2-CARBOXY-2-(4-HYDROXYPHENYL) HETNAM 2 MOX ACETYL]AMINO}-1-METHOXY-2-OXOETHYL]-5-METHYLIDENE-5,6- HETNAM 3 MOX DIHYDRO-2H-1,3-OXAZINE-4-CARBOXYLIC ACID HETNAM CL CHLORIDE ION HETSYN 3P7 MOXALACTAM DERIVATIVE (OPEN FORM) HETSYN MOX MOXALACTAM DERIVATIVE (OPEN FORM) FORMUL 3 3P7 C18 H18 N2 O9 FORMUL 4 MOX C18 H18 N2 O9 FORMUL 5 CL CL 1- FORMUL 6 HOH *242(H2 O) HELIX 1 1 ASP A 21 GLN A 34 1 14 HELIX 2 2 CYS A 61 THR A 63 5 3 HELIX 3 3 PHE A 64 ALA A 78 1 15 HELIX 4 4 ASP A 90 LEU A 94 5 5 HELIX 5 5 ALA A 98 VAL A 105 1 8 HELIX 6 6 VAL A 112 LEU A 122 1 11 HELIX 7 7 ASP A 124 GLY A 136 1 13 HELIX 8 8 GLY A 137 LEU A 148 1 12 HELIX 9 9 PRO A 160 THR A 164 5 5 HELIX 10 10 THR A 175 GLY A 189 1 15 HELIX 11 11 THR A 193 GLY A 206 1 14 HELIX 12 12 THR A 213 LEU A 218 5 6 HELIX 13 13 GLN A 262 GLN A 279 1 18 HELIX 14 14 PHE B 22 ASN B 33 1 12 HELIX 15 15 CYS B 61 THR B 63 5 3 HELIX 16 16 PHE B 64 ALA B 78 1 15 HELIX 17 17 ASP B 90 LEU B 94 5 5 HELIX 18 18 ALA B 98 VAL B 105 1 8 HELIX 19 19 VAL B 112 LEU B 122 1 11 HELIX 20 20 ASP B 124 GLY B 136 1 13 HELIX 21 21 GLY B 137 LEU B 148 1 12 HELIX 22 22 THR B 175 GLY B 189 1 15 HELIX 23 23 THR B 193 GLY B 206 1 14 HELIX 24 24 THR B 213 LEU B 218 5 6 HELIX 25 25 GLN B 262 GLN B 279 1 18 SHEET 1 A 5 LEU A 48 TYR A 52 0 SHEET 2 A 5 LYS A 36 SER A 43 -1 N LEU A 41 O ILE A 49 SHEET 3 A 5 LYS A 249 ASN A 257 -1 O TYR A 255 N GLY A 38 SHEET 4 A 5 GLY A 235 ILE A 243 -1 N ALA A 240 O LEU A 252 SHEET 5 A 5 VAL A 223 CYS A 231 -1 N GLY A 229 O ASN A 237 SHEET 1 B 2 PHE A 58 ALA A 59 0 SHEET 2 B 2 THR A 173 THR A 174 -1 O THR A 174 N PHE A 58 SHEET 1 C 2 LYS A 86 HIS A 88 0 SHEET 2 C 2 TYR A 109 THR A 111 -1 O MET A 110 N LEU A 87 SHEET 1 D 5 LEU B 48 TYR B 52 0 SHEET 2 D 5 LYS B 36 SER B 43 -1 N LEU B 41 O ILE B 49 SHEET 3 D 5 LYS B 249 ASN B 257 -1 O TYR B 255 N GLY B 38 SHEET 4 D 5 GLY B 235 ILE B 243 -1 N ALA B 240 O LEU B 252 SHEET 5 D 5 VAL B 223 SER B 230 -1 N GLY B 229 O ASN B 237 SHEET 1 E 2 PHE B 58 ALA B 59 0 SHEET 2 E 2 THR B 173 THR B 174 -1 O THR B 174 N PHE B 58 SHEET 1 F 2 LYS B 86 HIS B 88 0 SHEET 2 F 2 TYR B 109 THR B 111 -1 O MET B 110 N LEU B 87 SSBOND 1 CYS A 61 CYS A 231 1555 1555 2.00 SSBOND 2 CYS B 61 CYS B 231 1555 1555 2.03 LINK OG SER A 62 C1 3P7 A 301 1555 1555 1.61 LINK OG SER B 62 C1 MOX B 301 1555 1555 1.86 CISPEP 1 GLU A 159 PRO A 160 0 3.82 SITE 1 AC1 17 SER A 62 LYS A 65 TYR A 97 SER A 123 SITE 2 AC1 17 ASN A 125 GLU A 159 ASN A 163 THR A 209 SITE 3 AC1 17 LYS A 227 THR A 228 GLY A 229 SER A 230 SITE 4 AC1 17 HOH A 406 HOH A 415 HOH A 431 HOH A 497 SITE 5 AC1 17 HOH A 503 SITE 1 AC2 10 CYS B 61 SER B 62 LYS B 65 TYR B 97 SITE 2 AC2 10 SER B 123 ASN B 125 LYS B 227 THR B 228 SITE 3 AC2 10 GLY B 229 SER B 230 SITE 1 AC3 5 CYS B 61 SER B 62 THR B 63 GLY B 229 SITE 2 AC3 5 ASN B 237 CRYST1 70.530 80.910 86.640 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014178 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012359 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011542 0.00000